Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.

Autores de IIS La Fe

• Mariam Aguas Peris

  Autor

Participantes ajenos a IIS La Fe

• Argüelles-Arias F
• Castro-Laria L
• Lobatón T
• Rojas-Feria M
• Barreiro-de Acosta M
• Soto-Escribano P
• Calvo-Moya M
• Ginard-Vicens D
• Chaparro-Sánchez M
• Hernández-Durán M
• Castro-Senosiain B
• Fernández-Villaverde A
• García-Sánchez V
• Domínguez-Muñoz E
• Caunedo-Álvarez A
• Herrerías-Gutiérrez JM

Grupos

• Enfermedad Inflamatoria Intestinal

Abstract

Pyoderma gangrenosum is a serious cutaneous complication seen in approximately 1 % of patients with inflammatory bowel disease (IBD). Oral corticosteroids are the mainstay treatment, although the evidence supporting their use is weak.